Skip to content
Back to AEIS

Advanced Energy Industries Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
63
Purchases
0
Sales
63
Purchase value
$0.00
Sale value
$35.34M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

John DonagheyEVP, Global Sales
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 11, 20260001940410-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF13,238$236.95$767.24K13,038Direct
Filing footnotes · 1
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2026.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 5, 20260001770310-26-000016
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF1F2265$200.02$53.01K7,417IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Oct 7, 2026Period of report Oct 5, 20260001770310-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 5, 2026
Common StockF1F2270$304.76$82.29K7,682IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Elizabeth Karpinski VonneEVP, General Counsel
4Rule 10b5-1 plan disclosed
Filed Sep 10, 2026Period of report Sep 8, 20260001923149-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Common StockF1F2632$288.14$182.10K9,177Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F2Amount includes 40.984 shares acquired through the Dividend Reinvestment Plan. The numbers reported herein are rounded to the nearest number.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Sep 10, 2026Period of report Sep 8, 20260001770310-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Common StockF1F2265$288.14$76.36K7,952IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Elizabeth Karpinski VonneEVP, General Counsel
4Rule 10b5-1 plan disclosed
Filed Aug 27, 2026Period of report Aug 27, 20260001923149-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 27, 2026
Common StockF1F2907$290.05$263.08K9,805Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F2Amount includes 36.885 shares acquired through the Dividend Reinvestment Plan. The numbers reported herein are rounded to the nearest number.
Open on SEC EDGAR
Eduardo Bernal AcebedoEVP and COO
4Rule 10b5-1 plan disclosed
Filed Aug 20, 2026Period of report Aug 18, 20260001881031-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF1F2406$309.73$125.75K47,474Direct
SaleAug 18, 2026
Common StockF1F3568$310.75$176.51K46,906Direct
SaleAug 18, 2026
Common StockF1F42,951$311.80$920.12K43,955Direct
SaleAug 18, 2026
Common StockF1F53,998$312.65$1.25M39,957Direct
SaleAug 18, 2026
Common StockF1F65,062$313.82$1.59M34,895Direct
SaleAug 18, 2026
Common StockF1F73,103$314.92$977.20K31,792Direct
SaleAug 18, 2026
Common StockF1F82,180$315.66$688.14K29,612Direct
SaleAug 18, 2026
Common StockF1F91,280$316.92$405.66K28,332Direct
SaleAug 18, 2026
Common StockF1F10480$318.62$152.94K27,852Direct
SaleAug 18, 2026
Common StockF1F111,403$319.41$448.13K26,449Direct
SaleAug 18, 2026
Common StockF1F12720$320.81$230.98K25,729Direct
SaleAug 18, 2026
Common StockF1F13416$322.14$134.01K25,313Direct
SaleAug 18, 2026
Common StockF1F14425$323.28$137.39K24,888Direct
SaleAug 18, 2026
Common StockF1F15335$324.44$108.69K24,553Direct
SaleAug 18, 2026
Common StockF1F16407$327.82$133.42K24,146Direct
SaleAug 18, 2026
Common StockF1F17280$328.74$92.05K23,866Direct
SaleAug 18, 2026
Common StockF1F18120$330.45$39.65K23,746Direct
SaleAug 18, 2026
Common StockF1F19637$322.64$205.52K23,109Direct
Filing footnotes · 19
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F10Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $318.11 to $318.95, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  3. F11Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $319.12 to $319.93, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  4. F12Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $320.35 to $321.04, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  5. F13Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $322.13 to $322.81, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  6. F14Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $323.14 to $324.13, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  7. F15Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $324.17 to $324.62, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  8. F16Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $327.27 to $327.89, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  9. F17Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $328.74 to $328.75, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  10. F18Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $330.10 to $330.64, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  11. F19Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $332.61 to $332.68, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  12. F2Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $309.13 to $310.05, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  13. F3Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $310.19 to $311.09, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  14. F4Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $311.23 to $312.22, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  15. F5Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $312.23 to $313.19, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  16. F6Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $313.30 to $314.28, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  17. F7Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $314.31 to $315.28, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  18. F8Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $315.31 to $316.20, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  19. F9Represents the weighted average sale price.These shares were sold in multiple transactions at prices ranging from $316.50 to $317.19, inclusive.The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
Open on SEC EDGAR
Elizabeth Karpinski VonneEVP, General Counsel
4Rule 10b5-1 plan disclosed
Filed Aug 19, 2026Period of report Aug 18, 20260001923149-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF1F2908$332.68$302.07K10,712Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026
  2. F2Amount includes 36.885 shares acquired through the Dividend Reinvestment Plan. The numbers reported herein are rounded to the nearest number.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 5, 20260001770310-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 5, 2026
Common StockF1F2270$345.00$93.15K8,217IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Brian ShirleyDirector
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 15, 20260001353179-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common StockF1F21,234$372.35$459.48K6,663Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.
  2. F2Mr. Shirley transferred all shares out of The Shirley Family Trust and into the account held directly in his name on October 7, 2025. This was a mere change in the form of beneficial ownership and no change in Mr. Shirley's pecuniary interest. Subsequent Form 4 filings inadvertently continued to report the shares as indirectly held by Mr. Shirley in the trust.
Open on SEC EDGAR
Elizabeth Karpinski VonneEVP, General Counsel
4Rule 10b5-1 plan disclosed
Filed Apr 20, 2026Period of report Apr 16, 20260001923149-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F2966$369.40$356.84K11,616Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025.
  2. F2Amount includes 33.198 shares acquired through the Dividend Reinvestment Plan. The numbers reported herein are rounded to the nearest number.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Apr 16, 2026Period of report Apr 15, 20260001770310-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 15, 2026
Common StockF1F2240$380.52$91.32K6,174IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Paul R OldhamEVP, CFO
4Rule 10b5-1 plan disclosed
Filed Mar 19, 2026Period of report Mar 18, 20260001421764-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 18, 2026
Common StockF1F24,314$315.99$1.36M22,217Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2025.
  2. F2Includes 1,158 shares previously omitted from the Column 5 total due to an administrative error in a Form 4 originally filed on February 21, 2025, which was corrected by an amendment thereto filed on March 19, 2026.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Feb 17, 20260001770310-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF1F2240$312.59$75.02K6,414IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Brian ShirleyDirector
4Rule 10b5-1 plan disclosed
Filed Mar 13, 2026Period of report Mar 13, 20260001353179-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common StockF11,234$310.19$382.77K5,584IndirectBy The Shirley Family Trust
Filing footnotes · 1
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.
Open on SEC EDGAR
Stephen Douglas KelleyDirector · President and CEO
4Rule 10b5-1 plan disclosed
Filed Mar 12, 2026Period of report Mar 10, 20260001443674-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common StockF1543$305.48$165.88K129,833Direct
SaleMar 10, 2026
Common StockF1F2876$306.87$268.82K128,957Direct
SaleMar 10, 2026
Common StockF1F31,112$306.96$341.34K127,845Direct
SaleMar 10, 2026
Common StockF1F41,224$309.77$379.16K126,621Direct
SaleMar 10, 2026
Common StockF1F53,330$311.88$1.04M123,291Direct
SaleMar 10, 2026
Common StockF1F63,718$313.80$1.17M119,573Direct
SaleMar 10, 2026
Common StockF1F75,678$314.82$1.79M113,895Direct
SaleMar 10, 2026
Common StockF1F82,312$315.88$730.31K111,583Direct
SaleMar 10, 2026
Common StockF1F92,309$317.21$732.44K109,274Direct
SaleMar 10, 2026
Common StockF1F107,229$317.94$2.30M102,045Direct
SaleMar 10, 2026
Common StockF1F1113,278$319.05$4.24M88,767Direct
SaleMar 10, 2026
Common StockF1F127,535$319.90$2.41M81,232Direct
SaleMar 10, 2026
Common StockF1F13856$321.13$274.89K80,376Direct
Filing footnotes · 13
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2025.
  2. F10Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $317.67 to $318.64, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  3. F11Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $318.69 to $319.62, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  4. F12Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $319.74 to $320.41, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  5. F13Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $320.81 to $321.35, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  6. F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $306.79 to $307.21, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  7. F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $307.89 to $308.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  8. F4Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $309.68 to $310.02, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  9. F5Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $311.81 to $312.19, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  10. F6Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $313.15 to $314.09, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  11. F7Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $314.28 to $315.05, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  12. F8Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $315.36 to $315.91, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  13. F9Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $316.56 to $317.50, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
Open on SEC EDGAR
John A RoushDirector
4Rule 10b5-1 plan disclosed
Filed Mar 6, 2026Period of report Mar 4, 20260001308225-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 4, 2026
Common StockF1F21,200$319.78$383.74K36,618Direct
SaleMar 4, 2026
Common StockF1500$320.76$160.38K36,118Direct
SaleMar 4, 2026
Common StockF1F31,728$322.32$556.97K34,390Direct
SaleMar 4, 2026
Common StockF1500$323.79$161.90K33,890Direct
SaleMar 4, 2026
Common StockF1F43,291$324.29$1.07M30,599Direct
SaleMar 4, 2026
Common StockF1F52,706$325.26$880.15K27,893Direct
SaleMar 4, 2026
Common StockF1F6300$326.75$98.03K27,593Direct
Filing footnotes · 6
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025.
  2. F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $319.22 to $320.19, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  3. F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $322.10 to $323.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  4. F4Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $323.89 to $324.87, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  5. F5Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $324.99 to $325.74, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  6. F6Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $326.50 to $327.26, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
Open on SEC EDGAR
Bernard Raymond Colpitts JRSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001699662-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 3, 2026
Common StockF4F51,104$325.60$359.46K1,647Direct
Filing footnotes · 7
  1. F1On March 1, 2024, the reporting person was granted 2,938 restricted stock units ("RSUs") vesting in three equal installments beginning on the first anniversary of the grant date, of which the second installment vested on March 1, 2026. RSUs convert into common stock on a one-for-one basis.
  2. F2On March 1, 2025, the reporting person was granted 2,949 restricted stock units ("RSUs") vesting in three equal installments beginning on the first anniversary of the grant date, of which the first installment vested on March 1, 2026. RSUs convert into common stock on a one-for-one basis.
  3. F3Payment of tax liability by withholding securities incident to vesting of RSUs.
  4. F4The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025.
  5. F5Represents 1,647 unvested restricted stock units.
  6. F6These employee RSUs were issued pursuant to the Company's Amended and Restated 2023 Omnibus Incentive Plan ("LTI Plan") and will vest in three equal installments beginning on the first anniversary of the grant date.
  7. F7These performance share awards were issued pursuant to the LTI Plan at 100% of target, have a three-year performance period, and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the three-year performance period will be canceled.
Open on SEC EDGAR
Elizabeth Karpinski VonneEVP, General Counsel
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 23, 20260001193125-26-067686
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF1964$328.42$316.60K11,683Direct
SaleFeb 23, 2026
Common StockF1F20.001$329.76$0.3311,683Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025.
  2. F2Represents 3,065 shares of unvested restricted stock units and 8,618 shares of common stock.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 17, 20260001193125-26-056775
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F2240$311.04$74.65K6,654IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Lanesha MinnixDirector
4
Filed Feb 18, 2026Period of report Feb 13, 20260001193125-26-056753
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common StockF11,000$316.625$316.63K4,585Direct
Filing footnotes · 1
  1. F1Amount includes 2.409 shares acquired through the Dividend Reinvestment Plan. The numbers reported herein rounded down to the nearest number.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Jan 16, 2026Period of report Jan 15, 20260001193125-26-015133
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 15, 2026
Common StockF1F2240$247.00$59.28K6,894IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 15, 20250001193125-25-320288
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 15, 2025
Common StockF1F2240$218.40$52.42K7,134IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR
Tina DonikowskiDirector
4Rule 10b5-1 plan disclosed
Filed Dec 5, 2025Period of report Dec 4, 20250001193125-25-309399
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 4, 2025
Common StockF12,257$210.33$474.71K8,248Direct
Filing footnotes · 1
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025.
Open on SEC EDGAR
Paul R OldhamEVP, CFO
4Rule 10b5-1 plan disclosed
Filed Nov 21, 2025Period of report Nov 19, 20250001193125-25-291217
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 19, 2025
Common StockF1F3F48,174$203.11$1.66M24,792Direct
Filing footnotes · 4
  1. F1The reported exercise of options and sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2025.
  2. F2Payment of tax liability and option exercise price by withholding securities incident to options exercised and same-day-sale.
  3. F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.07 to $203.14, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  4. F4Represents 3,153 shares of unvested restricted stock units and 21,639 shares of common stock.
Open on SEC EDGAR
Bernard Raymond Colpitts JRSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Nov 20, 2025Period of report Nov 18, 20250001193125-25-289381
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 18, 2025
Common StockF1F22,407$196.82$473.75K1,647Direct
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025.
  2. F2Represents 1,647 shares of unvested restricted stock units.
Open on SEC EDGAR
Anne DelSantoDirector
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2025Period of report Nov 17, 20250001193125-25-285699
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 17, 2025
Common StockF1F2240$200.27$48.06K7,374IndirectBy The Delsanto Family Trust
Filing footnotes · 2
  1. F1The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
  2. F2Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.